Asieris and SPH Kyuan Trade Announce Import and Distribution Strategic Partnership to Accelerate the Commercialization of Cevira®

Shanghai, China, March 24, 2026 – Asieris Pharmaceuticals (688176.SH) today announced a strategic partnership with Keyuan Xinhai (Beijing) Medical Products Trade Co., Ltd. (SPH Kyuan Trade), a subsidiary of Shanghai Pharma. The two companies will engage in in-depth strategic cooperation on the import and distribution of Cevira® in China, leveraging their respective strengths to jointly […] The post Asieris and SPH Kyuan Trade Announce Import and Distribution Strategic Partnership to Accelerate the Commercialization of Cevira® appeared first on Asieris Pharmaceuticals .